Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AVERAGE CHOLESTEROL LEVELS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 332 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Thompson, PL
      Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients

      ATHEROSCLEROSIS SUPPLEMENTS
    2. Tonkin, AM
      Clinical relevance of statins: their role in secondary prevention

      ATHEROSCLEROSIS SUPPLEMENTS
    3. Braunwald, E
      Changing the practice of cardiovascular medicine

      ATHEROSCLEROSIS SUPPLEMENTS
    4. Kobashigawa, JA
      Statins as immunosuppressive agents - Statins as a newly recognized type of immunomodulator

      LIVER TRANSPLANTATION
    5. Murphy, M; Shepherd, J
      Healthy ageing: Statin therapy opportunities - The 72nd European Atherosclerosis Society Congress - Foreword

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    6. Gaw, A
      Healthy ageing: addressing acute coronary syndrome?

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    7. Aikawa, M; Libby, P
      Vascular inflammation and activation: new targets for lipid lowering

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    8. Game, FL; Bartlett, WA; Bayly, GR; Jones, AF
      Comparative accuracy of cardiovascular risk prediction methods in patientswith diabetes mellitus

      DIABETES OBESITY & METABOLISM
    9. Burnett, TR; Watts, GF
      Therapeutic considerations for postprandial dyslipidaemia

      DIABETES OBESITY & METABOLISM
    10. Bandyopadhyay, S; Bayer, AJ; O'Mahony, MS
      Age and gender bias in statin trials

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    11. Jackson, G
      Statins in acute coronary syndromes: from bench to bedside

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    12. Haq, IU; Ramsay, LE; Wallis, EJ; Isles, CG; Ritchie, LD; Jackson, PR
      Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey

      HEART
    13. Doggrell, SA
      Statins in the 21st century: end of the simple story?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    14. de Freitas, GR; Bogousslavsky, J
      Primary stroke prevention

      EUROPEAN JOURNAL OF NEUROLOGY
    15. Chaiyakunapruk, N; Boudreau, D; Ramsey, SD
      Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes

      JOURNAL OF CARDIOVASCULAR RISK
    16. Holdaas, H; Fellstrom, B; Holme, I; Nyberg, G; Fauchald, P; Jardine, A; Gronhagen-Riska, C; Madser, S; Neumayer, HH; Cole, E; Maes, B; Weinreich, T; Olsson, AG; Pedersen, TR; Benghozi, R; Hartmann, A
      Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol (R) in Renal Transplantation) study design and baseline data

      JOURNAL OF CARDIOVASCULAR RISK
    17. Franzosi, MG; Brunetti, M; Marchioli, R; Marfisi, RM; Tognoni, G; Valagussa, F
      Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction - Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial

      PHARMACOECONOMICS
    18. McKenney, JM
      Lipid management: Tools for getting to the goal

      AMERICAN JOURNAL OF MANAGED CARE
    19. Mason, CM
      Identifying all suspects: Case studies

      AMERICAN JOURNAL OF MANAGED CARE
    20. Pedersen, T; Gaw, A
      Statins - Similarities and differences

      AMERICAN JOURNAL OF MANAGED CARE
    21. Eckel, RH
      Perspectives on vascular biology and diabetes

      JOURNAL OF INVESTIGATIVE MEDICINE
    22. Zambon, A; Brown, BG; Deeb, SS; Brunzell, JD
      Hepatic lipase as a focal point for the development and treatment of coronary artery disease

      JOURNAL OF INVESTIGATIVE MEDICINE
    23. Diomede, L; Albani, D; Sottocorno, M; Donati, MB; Bianchi, M; Fruscella, P; Salmona, M
      In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    24. Takemoto, M; Liao, JK
      Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    25. Cheng, JWM
      Recognition, pathophysiology, and management of acute myocardial infarction

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    26. O'Donnell, DC; Brown, CM; Piziak, VK
      Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    27. Bismuth, J; Klitfod, L; Sillesen, H
      The lack of cardiovascular risk factor management in patients with critical limb ischaemia

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    28. Archer, DF
      Progestogen effects on coronary arteries: the need for definitive clinicaltrials

      MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
    29. Aldridge, MA; Ito, MK
      Colesevelam hydrochloride: A novel bile acid-binding resin

      ANNALS OF PHARMACOTHERAPY
    30. Marcus, A
      Current lipid-lowering strategies for the treatment of diabetic dyslipidemia: An integrated approach to therapy

      ENDOCRINOLOGIST
    31. Steiner, G
      The use of fibrates and of statins in preventing atherosclerosis in diabetes

      CURRENT OPINION IN LIPIDOLOGY
    32. Gotto, AM; Farmer, JA
      Pleiotropic effects of statins: do they matter?

      CURRENT OPINION IN LIPIDOLOGY
    33. Hornig, B; Drexler, H
      Reversal of endothelial dysfunction in humans

      CORONARY ARTERY DISEASE
    34. Halcox, JPJ; Quyyumi, AA
      Coronary vascular endothelial function and myocardial ischemia: why shouldwe worry about endothelial dysfunction?

      CORONARY ARTERY DISEASE
    35. Laakso, M
      Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention

      JOURNAL OF INTERNAL MEDICINE
    36. Thomas, HP
      Classical cardiovascular risk factors: Prognostic value and treatment in elderly patients

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    37. Roesen, P; Ferber, P; Tschoepe, D
      Macrovascular disease in diabetes: current status

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    38. Boger, RH
      Drug interactions of them statins and consequences for drug selection

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    39. Bernini, F; Poli, A; Paoletti, R
      Safety of HMG-CoA reductase inhibitors: Focus on atorvastatin

      CARDIOVASCULAR DRUGS AND THERAPY
    40. Garber, AJ; Karlsson, FO
      Treatment of dyslipidemia in diabetes

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    41. Game, FL; Jones, AF
      Coronary heart disease risk assessment in diabetes mellitus - a comparisonof PROCAM and Framingham risk assessment functions

      DIABETIC MEDICINE
    42. Walter, DH; Fichtlscherer, S; Britten, MB; Rosin, P; Auch-Schwelk, W; Schachinger, V; Zeiher, AM
      Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    43. McPhail, IR; Spittell, PC; Weston, SA; Bailey, KR
      Intermittent claudication: An objective office-based assessment

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    44. Scripture, CD; Pieper, JA
      Clinical pharmacokinetics of fluvastatin

      CLINICAL PHARMACOKINETICS
    45. Jackson, PR; Wallis, EJ; Haq, IU; Ramsay, LE
      Statins for primary prevention: at what coronary risk is safety assured?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    46. Martinez-Gonzalez, J; Llorente-Cortes, V; Badimon, L
      Cellular and molecular biology of atherosclerotic lesions

      REVISTA ESPANOLA DE CARDIOLOGIA
    47. Elisaf, M
      The treatment of coronary heart disease: An update - Part 1: An overview of the risk factors for cardiovascular disease

      CURRENT MEDICAL RESEARCH AND OPINION
    48. Niemeijer-Kanters, SDJM; Banga, JD; Erkelens, DW
      Lipid-lowering therapy in diabetes mellitus

      NETHERLANDS JOURNAL OF MEDICINE
    49. Taylor, AJ; Grace, K; Swiecki, J; Hyatt, R; Gibbs, H; Sheikh, M; O'Malley, PG; Lowenthal, SP; West, M; Spain, J; Maneval, K; Jones, DL
      Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion program

      PHARMACOTHERAPY
    50. Straka, RJ; Taheri, R; Cooper, SL; Tan, AWH; Smith, JC
      Assessment of hypercholesterolemia control in a managed care organization

      PHARMACOTHERAPY
    51. Tsuyuki, RT; Bungard, TJ
      Poor adherence with hypolipidemic drugs: A lost opportunity

      PHARMACOTHERAPY
    52. Tsuyuki, RT; Bungard, T
      Do hypolipidemic drugs lower medical expenses? Authors' reply

      PHARMACOTHERAPY
    53. Tonelli, M; Bohm, C; Pandeya, S; Gill, J; Levin, A; Kiberd, BA
      Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

      AMERICAN JOURNAL OF KIDNEY DISEASES
    54. Sever, PS; Dahlof, B; Poulter, NR; Wedel, H; Beevers, G; Caulfield, M; Collins, R; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J
      Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial

      JOURNAL OF HYPERTENSION
    55. Arad, Y; Newstein, D; Roth, M; Guerci, AD
      Rationale and design of the St. Francis Heart Study: A randomized clinicaltrial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcification

      CONTROLLED CLINICAL TRIALS
    56. van Hout, BA; Simoons, ML
      Cost-effectiveness of HMG coenzyme reductase inhibitors - Whom to treat?

      EUROPEAN HEART JOURNAL
    57. Ridker, PM
      Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

      EUROPEAN HEART JOURNAL
    58. Musial, J; Undas, A; Gajewski, P; Jankowski, M; Sydor, W; Szczeklik, A
      Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    59. Isaacsohn, J; Insull, W; Stein, E; Kwiterovich, P; Ma, P; Brazg, R; Dujovne, CA; Shan, M; Shugrue-Crowley, E; Ripa, S; Tota, R
      Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia

      CLINICAL CARDIOLOGY
    60. Waters, DD
      What do the statin trials tell us?

      CLINICAL CARDIOLOGY
    61. Gotto, AM
      How do we achieve optimal cardiovascular risk reduction?

      CLINICAL CARDIOLOGY
    62. Hennekens, CH
      Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease

      CLINICAL CARDIOLOGY
    63. Auer, J; Berent, R; Eber, B
      Lessons learned from statin trials

      CLINICAL CARDIOLOGY
    64. Choe, SC; Kim, HS; Jeong, TS; Bok, SH; Park, YB
      Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    65. Unlu, S; Clunn, G; Schachter, M; Demoliou-Mason, C; Hughes, AD
      Action of an HMG CoA reductase inhibitor, lovastatin, on apoptosis of untransformed and ts-SV40 transformed human smooth muscle cells derived from saphenous vein

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    66. Sabia, H; Prasad, P; Smith, HT; Stoltz, RR; Rothenberg, P
      Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    67. McPherson, R; Hanna, K; Agro, A; Braeken, A
      Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

      CLINICAL THERAPEUTICS
    68. van Dam, MJ; Penn, HJAM; den Hartog, FR; Kragten, HA; Trip, MD; Buirma, RJA; Kastelein, JJP
      A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: A randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease

      CLINICAL THERAPEUTICS
    69. Ballantyne, CM; Pazzucconi, F; Pinto, X; Reckless, JP; Stein, E; McKenney, J; Bortolini, M; Chiang, YT
      Efficacy and tolerability of fluvastatin extended-release delivery system:A pooled analysis

      CLINICAL THERAPEUTICS
    70. Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS
      Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

      LANCET
    71. Albert, MA; Danielson, E; Rifai, N; Ridker, PM
      Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    72. Simpson, RJ
      Placing PRINCE in perspective

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    73. Stenestrand, U; Wallentin, L
      Early statin treatment following acute myocardial infarction and 1-year survival

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    74. Dayspring, TD
      Prevention of a first myocardial infarction

      JOURNAL OF CLINICAL PHARMACOLOGY
    75. Holdaas, H; Jardine, AG; Wheeler, DC; Brekke, IB; Conlon, PJ; Fellstrom, B; Hammad, A; Holme, I; Isoniemi, H; Moore, R; Rowe, PA; Sweny, P; Talbot, DA; Wadstrom, J; Ostraat, O
      Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial

      KIDNEY INTERNATIONAL
    76. De Freitas, GR; Bogousslavsky, J
      Primary stroke prevention

      ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA
    77. Federman, DG; Hussain, F; Walters, JB
      Fatal rhabdomyolysis caused by lipid-lowering therapy

      SOUTHERN MEDICAL JOURNAL
    78. Marcus, AO
      Lipid disorders in patients with type 2 diabetes - Meeting the challenges of early, aggressive treatment

      POSTGRADUATE MEDICINE
    79. Braganza, DM; Bennett, MR
      New insights into atherosclerotic plaque rupture

      POSTGRADUATE MEDICAL JOURNAL
    80. Igel, M; Sudhop, T; vonBergmann, K
      Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins)

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    81. Isaacsohn, J; Zinny, M; Mazzu, A; Lettieri, J; Heller, AH
      Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    82. Ridker, PM; Rifai, N; Clearfield, M; Downs, JR; Weis, SE; Miles, JS; Gotto, AM
      Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

      NEW ENGLAND JOURNAL OF MEDICINE
    83. Sheu, WHH; Jeng, CY; Lee, WJ; Lin, SY; Pei, D; Chen, YT
      Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia

      METABOLISM-CLINICAL AND EXPERIMENTAL
    84. Fernandez-Miranda, C; Aranda, JL; Paz, M; Nunez, V; Gonzalez, PG; Diaz-Rubio, P; Larumbe, S; Gomez-Izquierdo, MT
      Silent carotid atherosclerosis in patients with coronary disease

      MEDICINA CLINICA
    85. Plata, MCJ
      Antilipemic agents and evidence based medicine

      MEDICINA CLINICA
    86. Forge, BH; Briganti, EM
      Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines?

      MEDICAL JOURNAL OF AUSTRALIA
    87. Watts, GF; Dimmitt, SB; Barter, PJ
      Normocholesterolaemic dyslipidaemia: is there a role for fibrates?

      MEDICAL JOURNAL OF AUSTRALIA
    88. Cucchiara, B; Kasner, SE
      Use of statins in CNS disorders

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    89. Solheim, S; Seljeflot, I; Arnesen, H; Eritsland, J; Eikvar, L
      Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks

      ATHEROSCLEROSIS
    90. Alonso, R; Mata, P; De Andres, R; Villacastin, BP; Martinez-Gonzalez, J; Badimon, L
      Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin

      ATHEROSCLEROSIS
    91. Bissonnette, R; Treacy, E; Rozen, R; Boucher, B; Cohn, JS; Genest, J
      Fenofibrate raises plasma homocysteine levels in the fasted and fed states

      ATHEROSCLEROSIS
    92. Thompson, PL
      Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients

      ATHEROSCLEROSIS
    93. Tonkin, AM
      Clinical relevance of statins: their role in secondary prevention

      ATHEROSCLEROSIS
    94. Braunwald, E
      Changing the practice of cardiovascular medicine

      ATHEROSCLEROSIS
    95. Davidson, MH
      Safety profiles for the HMG-CoA reductase inhibitors - Treatment and trust

      DRUGS
    96. Castano, G; Mas, R; Fernandez, L; Illnait, J; Gamez, R; Fernandez, JC
      Comparison of two regimens of policosanol administered at 20 mg/d in patients with type II hypercholesterolemia: A randomized, double-blind, placebo-controlled study

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    97. Rifai, N; Ridker, PM
      High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease

      CLINICAL CHEMISTRY
    98. Blake, GJ; Ridker, PM
      Novel clinical markers of vascular wall inflammation

      CIRCULATION RESEARCH
    99. Schartl, M; Bocksch, W; Koschyk, DH; Voelker, W; Karsch, KR; Kreuzer, J; Hausmann, D; Beckmann, S; Gross, M
      Use of intravascular ultrasound to compare effects of different strategiesof lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease

      CIRCULATION
    100. White, CW; Gobel, FL; Campeau, L; Knatterud, GL; Forman, SA; Forrester, JS; Geller, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hunninghake, DB; Rosenberg, Y; Terrin, ML
      Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial

      CIRCULATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 21:07:05